Genesis HealthCare Co
A privately-owned Japanese genetic testing and research company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $13.4m | Late VC | |
| Total Funding | 000k | ||
Related Content
Established in 2004, Genesis Healthcare Co. stands as a significant player in Japan's genetic testing and research sector. The company was founded by Dr. Iri Sato Baran, whose background in biomedical sciences and doctoral studies at Tokai University School of Medicine provided a strong foundation for the company's scientific pursuits. Her journey began with a desire to make genetic information more accessible and to promote preventative healthcare in Japan, a vision that has driven the company's strategy.
Genesis Healthcare operates on a dual-front business model, catering to both consumers and the scientific community. Its direct-to-consumer brand, GeneLife, has established itself as a market leader in Japan, offering a range of at-home genetic testing kits. These kits, such as GeneLife Genesis 2.0 and GeneLife DIET, provide individuals with insights into their health risks, physical constitution, and ancestry, with the goal of encouraging proactive health management. The kits analyze DNA from saliva samples to deliver personalized reports.
On the B2B side, the company leverages its extensive genetic database, the largest in Asia, to provide research services and clinical testing. This division collaborates with medical institutions, research organizations, and corporate partners, utilizing advanced PCR, Microarray, and Next-Generation Sequencing (NGS) technologies. Revenue is generated through the sale of GeneLife testing kits to consumers and through fees for its research and testing services to institutional clients. A notable milestone was a strategic capital and business alliance with Rakuten in 2017, which integrated genetic testing services into the e-commerce giant's ecosystem, significantly expanding market reach.
The company also emphasizes its role in shaping the regulatory landscape for genetic testing in Japan, working with government bodies to establish guidelines for data security and accuracy. This focus on data integrity is crucial, as the company manages a substantial biobank and database, which also supports population-level genomic research initiatives.
Keywords: genetic testing, direct-to-consumer genetics, preventative healthcare, DNA analysis, bioinformatics, genomic research, personalized medicine, biobank, molecular diagnostics, nutrigenetics